A peer-reviewed neurology, neurosurgery and psychiatry journal publishing the latest research and reviews on the entire genre of neurological sciences.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
Background Physical activity has been associated with neuroprotective and immunomodulatory benefits, potentially influencing ...
Background Motor and cognitive dysfunctions are common and disabling features in multiple sclerosis (MS) that remain challenging to treat. Here, we aimed to explore the effect of exergames as a ...
Faculty of Medicine MS/MRI Research Group, University of British Columbia, Vancouver, Canada Helen Tremlett, PhD, Department of Medicine (Neurology), rm S178, 2211 Wesbrook Mall, University of British ...
1 National Institute for Health Research (NIHR) Biomedical Research Centre, South London & Maudsley NHS Foundation Trust and Institute of Psychiatry, King's College London, London, UK 2 Section of ...
3 Working Group ‘Deep Brain Stimulation in Psychiatry: Guidance for Responsible Research and Application’. This Working Group is organised by the Europäische ...
Correspondence to Dr A W Lemstra, Alzheimer Center & Department of Neurology, VU University Medical Center and Neuroscience Campus Amsterdam, De Boelelaan 1118, Amsterdam 1081 HZ, The Netherlands; ...
Objectives OCARINA II (NCT05232825) is a Phase III, randomised, open-label, controlled study of a novel subcutaneous formulation of ocrelizumab, designed to demonstrate non-inferior serum exposure of ...
Correspondence to Dr Nils Koch-Henriksen, The Danish Multiple Sclerosis Registry, Copenhagen University Hospital Rigshospitalet, Section 7801 Blegdamsvej 9, DK 2100 Copenhagen, Denmark; koch-henriksen ...
Wilson’s disease is an autosomal–recessive disorder of copper metabolism caused by mutations in ATP7B and associated with neurological, psychiatric, ophthalmological and hepatic manifestations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results